HS 8716-39-30-20 – Lowbed

Tariff data as of T2026-2, effective Sept 1, 2026, last verified Oct 21, 2026

US-origin goods: 25% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026)

Trailers and semi-trailers; other vehicles, not mechanically propelled; parts thereof. › Other › Lowbed

MFN duty rate

9.5 %

GST

5%

Unit of measure

NMB

Lowbed

Estimate duty & taxes · Get classification help

Preferential tariff rates

• GPT: 9.5%
• CPTPP – United Kingdom (CPUKT): Free
• Peru: Free
• LDCT: Free
• Chile: Free
• Colombia: Free
• Panama (PAT): Free
• Switzerland–Liechtenstein (SLT): Free
• CETA: Free
• CPTPP: Free
• Honduras (HNT): Free
• MXT/CUSMA (Mexico): Free
• Commonwealth Caribbean Countries Tariff (CCCT): Free
• UK: Free
• Costa Rica (CRT): Free
• Korea: Free
• Israel (CIAT): Free
• Norway (NT): Free
• Iceland: Free
• Jordan (JT): Free
• Ukraine: Free
• UST/CUSMA (US): Free

Preference requires qualifying origin and origin proof or certification.

Frequently asked questions

What is the MFN duty on Lowbed (HS 8716-39-30-20)?

The T2026-2 MFN rate for tariff item 8716.39.30 is 9.5%. Specific or compound rates require manual calculation. Classification and origin must be verified with CBSA.

What is the duty on HS 8716-39-30-20 from the US?

Qualifying US-origin goods with origin proof use UST/CUSMA at Free. US-origin goods: 25% surtax (United States Surtax Order (2026), SOR/2026-186, in force Sep 8, 2026) GST/HST and any applicable personal-import provincial tax are additional.

Which trade agreement rates apply to HS 8716-39-30-20?

GPT: 9.5%; CPTPP – United Kingdom (CPUKT): Free; Peru: Free; LDCT: Free; Chile: Free; Colombia: Free; Panama (PAT): Free; Switzerland–Liechtenstein (SLT): Free; CETA: Free; CPTPP: Free; Honduras (HNT): Free; MXT/CUSMA (Mexico): Free; Commonwealth Caribbean Countries Tariff (CCCT): Free; UK: Free; Costa Rica (CRT): Free; Korea: Free; Israel (CIAT): Free; Norway (NT): Free; Iceland: Free; Jordan (JT): Free; Ukraine: Free; UST/CUSMA (US): Free. Preferential treatment requires qualifying origin and certification. Rates are informational; CBSA is authoritative.